Jenna K Minami’s team found that knocking down CDKN2A can promote lipid peroxidation in GBM cells, selectively induce tumor ferroptosis, and thereby inhibit the malignant progression of glioblastoma (13). Here, CDKN2A is linked to neoplasm.